Protection against lung cancer patient plasma-induced lymphocyte suppression by ganoderma lucidum polysaccharides

Cellular Physiology and Biochemistry

Volumn 33, Issue 2, 2014, Pages 289-299

  Sun, Li Xin ^a   Li, Wei Dong ^b   Lin, Zhi Bin ^b   Duan, Xin Suo ^a   Li, Xue Fei ^a   Yang, Ning ^a   Lan, Tian Fei ^a   Li, Min ^b   Sun, Yu ^a   Yu, Min ^a   Lu, Jie ^a  

^a CHENGDE MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

CD69; Ganoderma lucidum polysaccharides; Granzyme B; Lung cancer; Lymphocyte activation; Perforin

Indexed keywords

CD69 ANTIGEN; DOXORUBICIN; GANODERMA LUCIDUM EXTRACT; GRANZYME B; PERFORIN; PHYTOHEMAGGLUTININ; INTERLEUKIN 10; POLYSACCHARIDE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; CANCER CONTROL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LUNG CANCER; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT; ANTIPROLIFERATIVE ACTIVITY; CANCER PATIENT; FLOW CYTOMETRY; GANODERMA LUCIDUM; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; WESTERN BLOTTING;

ANIMALIA; GANODERMA LUCIDUM;

AGED; ANIMALS; CELL PROLIFERATION; CYTOKINES; FEMALE; FUNGAL POLYSACCHARIDES; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; REISHI;

EID: 84893680724     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356669     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
3. Töpfer K, Kempe S, Müller N, Schmitz M, Bachmann M, Cartellieri M, Schackert G, Temme A: Tumor evasion from T cell surveillance. J Biomed Biotechnol 2011;2011:918471.
4. Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S: Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy 2012;4:291-304.
5. Frumento G, Piazza T, Di Carlo E, Ferrini S: Targeting tumor-related immunosuppression for cancer immunotherapy. Endocr Metab Immune Disord Drug Targets 2006;6:233-237.
6. Patel S, Vetale S, Teli P, Mistry R, Chiplunkar S: IL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2. J Cell Mol Med 2012;16:531-544.
7. González-Santiago AE, Mendoza-Topete LA, Sánchez-Llamas F, Troyo-Sanromán R, Gurrola-Díaz CM: TGF-β1 serum concentration as a complementary diagnostic biomarker of lung cancer: Establishment of a cut-point value. J Clin Lab Anal 2011;25:238-243.
8. Wójcik E, Jakubowicz J, Skotnicki P, Sas-Korczyńska B, Kulpa JK: IL-6 and VEGF in small cell lung cancer patients. Anticancer Res 2010;30:1773-1778.
9. Yang W, Bhandaru M, Pasham V, Bobbala D, Zelenak C, Jilani K, Rotte A, Lang F: Effect of thymoquinone on cytosolic pH and Na+/H+ exchanger activity in mouse dendritic cells. Cell Physiol Biochem 2012;29:21-30.
10. Geldenhuys W, Mbimba T, Bui T, Harrison K, Sutariya V: Brain-Targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. J Drug Target 2011;19:837-845.
11. Zheng J, Zhang XX, Yu H, Taggart JE, Ding WQ: Zinc at cytotoxic concentrations affects posttranscriptional events of gene expression in cancer cells. Cell Physiol Biochem 2012;29:181-188.
12. Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP: Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target 2011;19:67-78.
13. Peschel W, Kump A, Prieto JM: Effects of 20-hydroxyecdysone, Leuzea carthamoides extracts, dexamethasone and their combinations on the NF-κB activation in HeLa cells. J Pharm Pharmacol 2011;63:1483-1495.
14. Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, Du SX: Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem 2012;30:123-136.
15. Moiola C, De Luca P, Cotignola J, Gardner K, Vazquez E, De Siervi A: Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription. Cell Physiol Biochem 2012;30:596-608.
16. Chan WK, Cheung CC, Law HK, Lau YL, Chan GC: Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J Hematol Oncol 2008;1:9.
17. Lin ZB: Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 2005;99:144-153.
18. Cao LZ, Lin ZB: Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett 2002;83:163-169.
19. Cao LZ, Lin ZB: Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol Sin 2003;24:321-326.
20. Zhu XL, Lin ZB: Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharmacol Sin 2005;26:1130-1137.
21. Zhu XL, Chen AF, Lin ZB: Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 2007;111:219-226.
22. Li WD, Zhang BD, Wei R, Liu JH, Lin ZB: Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line. Acta Pharmacol Sin 2008;29:620-627.
23. Sun LX, Chen LH, Lin ZB, Qin Y, Zhang JQ, Yang J, Ma J, Ye T, Li WD: Effects of Ganoderma lucidum polysaccharides on IEC-6 cell proliferation, migration and morphology of differentiation benefiting intestinal epithelium healing in vitro. J Pharm Pharmacol 2011;63:1595-1603.
24. Cao QZ, Lin ZB: Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 2006;78:1457-1463.
25. Cao QZ, Lin ZB: Antitumor and anti-Angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 2004;25:833-838.
26. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XF, Li XJ, Li M, Xing EH, Song YX, Jia J, Li WD: Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides. J Drug Target 2012;20:582-592.
27. Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, Ge ZH, Song YX, Xing EH, Li WD: Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol 2011;108:149-154.
28. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Song YX, Li XJ, Li M, Xing EH, Yang N, Li WD: Stronger cytotoxicity in CTLs with granzyme B and porforin was induced by Ganoderma lucidum polysaccharides acting on B16F10 cells. Biomed Prev Nutr 2012;2:113-118.
29. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, Li M, Xing EH, Jia J, Lan TF, Li WD: Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol 2011;63:725-735.
30. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li M, Xing EH, Lan YF, Jiang MM, Yang N, Li WD: Ganoderma lucidum polysaccharides counteract inhibition on CD71 and FasL expression by culture supernatant of B16F10 cells upon lymphocyte activation. Exp Ther Med 2013;5:1117-1122.
31. Lu J, Sun LX, Lin ZB, Duan XS, Ge ZH, Xing EH, Lan TF, Yang N, Li XJ, Li M, Li WD: Antagonism by Ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16F10 melanoma cells on macrophage. Phytother Res 2013; DOI: 10.1002/ptr.4980.
32. Wang YY, Khoo KH, Chen ST, Lin CC, Wong CH, Lin CH: Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: Functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem 2002;10:1057-1062.
33. Enewold L, Mechanic LE, Bowman ED, Zheng YL, Yu Z, Trivers G, Alberg AJ, Harris CC: Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2009;18:215-222.
34. Ozkaya S, Findik S, Dirican A, Atici AG: Long-Term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine. Exp Ther Med 2012;4:1035-1038.
35. Bettio D, Cariboni U, Venci A, Valente M, Spaggiari P, Alloisio M: Cytogenetic findings in lung cancer that illuminate its biological history from adenomatous hyperplasia to bronchioalveolar carcinoma to adenocarcinoma: A case report. Exp Ther Med 2012;4:1032-1034.
36. Chunhacha P, Sriuranpong V, Chanvorachote P: Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells. Oncol Lett 2013;5:1043-1047.
37. Mutlu H, Büyükçelik A, Kaya E, Kibar M, Seyrek E, Yavuz S, Calikuşu Z: Sunlight may increase the FDG uptake value in primary tumors of patients with non-small cell lung cancer. Oncol Lett 2013;5:773-776.
38. Mulligan JK, Young MR: Tumors induce the formation of suppressor endothelial cells in vivo. Cancer Immunol Immunother 2010;59:267-277.
39. Young MR: Protective mechanisms of head and neck squamous cell carcinomas from immune assault. Head Neck 2006;28:462-470.
40. Vazquez BN, Laguna T, Notario L, Lauzurica P: Evidence for an intronic cis-regulatory element within CD69 gene. Genes Immun 2012;13:356-362.
41. Natarajan K, Sawicki MW, Margulies DH, Mariuzza RA: Crystal structure of human CD69: A C-Type lectin-like activation marker of hematopoietic cells. Biochemistry 2000;39:14779-14786.
42. Ziegler SF, Ramsdell F, Alderson MR: The activation antigen CD69. Stem Cells 1994;12:456-465.
43. Goral S: The three-signal hypothesis of lymphocyte activation/targets for immunosuppression. Dial Transplant 2011;40:14-16.
44. Abraham RT, Weiss A: Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol 2004;4:301-308.
45. Anthony DA, Andrews DM, Watt SV, Trapani JA, Smyth MJ: Functional dissection of the granzyme family: Cell death and inflammation. Immunol Rev 2010;235:73-92.
46. Zhou F: Perforin: More than just a pore-forming protein. Int Rev Immunol 2010;29:56-76.
47. Bovenschen N, Kummer JA: Orphan granzymes find a home. Immunol Rev 2010;235:117-127.
48. Voskoboinik I, Dunstone MA, Baran K, Whisstock JC, Trapani JA: Perforin: Structure, function, and role in human immunopathology. Immunol Rev 2010;235:35-54.
49. Shimabukuro-Vornhagen A, Draube A, Liebig TM, Rothe A, Kochanek M, von Bergwelt-Baildon MS: The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-Activated B cells. J Exp Clin Cancer Res 2012;31:47.
50. Kalinski P: Regulation of immune responses by prostaglandin E2. J Immunol 2012;188:21-28.